2018
DOI: 10.1007/s00408-018-0146-2
|View full text |Cite
|
Sign up to set email alerts
|

Risk Stratification in Patients with Complicated Parapneumonic Effusions and Empyema Using the RAPID Score

Abstract: Our findings suggest that the RAPID score is a robust tool which could be used to identify patients with complicated parapneumonic effusions and empyema who may be at an increased risk of mortality, prolonged hospitalization, and who may incur a higher cost of treatment. Randomized controlled trials identifying the most effective initial treatment modality for medium- and high-risk patients are needed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
20
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(22 citation statements)
references
References 33 publications
1
20
0
Order By: Relevance
“…Categorisation of patients in to low risk (RAPID score 0-2), medium risk (RAPID score 3-4) and high risk (RAPID score 5-7) groups was associated with mortality at 3 months of 3%, 9% and 31%, respectively [108]. Since its publication, positive correlation of clinical outcomes with the RAPID score has been demonstrated [109] and prospective assessment has recently been completed in an international, multicentre study [110] due to publish later this year. This should add greater insight into its potential utility in the clinical setting.…”
Section: Risk Scoring and Altering The Treatment Pathwaymentioning
confidence: 99%
“…Categorisation of patients in to low risk (RAPID score 0-2), medium risk (RAPID score 3-4) and high risk (RAPID score 5-7) groups was associated with mortality at 3 months of 3%, 9% and 31%, respectively [108]. Since its publication, positive correlation of clinical outcomes with the RAPID score has been demonstrated [109] and prospective assessment has recently been completed in an international, multicentre study [110] due to publish later this year. This should add greater insight into its potential utility in the clinical setting.…”
Section: Risk Scoring and Altering The Treatment Pathwaymentioning
confidence: 99%
“…Staphylococcus aureus , Streptococcus pneumoniae , and Streptococcus pyogenes are frequently reported as causative bacteria of empyema, 5 while the Streptococcus anginosus group, an oral bacteria group, has been reported as the causative bacteria of intrathoracic abscess 4,6 . Empyema often develops in patients with immunodeficiency, who are termed “immunocompromised hosts.” 7 Patients with diabetes mellitus, chronic kidney disease, and malignancy history, as well as those undergoing any cancer therapies, may be at risk for empyema; however, a detailed analysis has not been performed due to its complex conditions and rarity 8 …”
Section: Introductionmentioning
confidence: 99%
“…Prognosis of empyema remains poor, and surgery has a high frequency of postoperative complications and relapse after treatment, especially in patients with a long duration between onset and treatment. 8,12,16 Identifying high-risk patients may be effective at reducing the rate of complications, as preventative measures can be taken prior to surgery. Some facilities have previously reported that preoperative serum albumin level was a good predictor for postoperative complications of acute empyema.…”
mentioning
confidence: 99%
“…Mortality rate increases 6-7 fold higher in complicated cases compared to pneumonias non-complicated PPE (5). In the United States, over 1 million PPEs were reported annually (6,7,8). Early intervention by proper antibiotics is the main point of the management of PPEs.…”
Section: Introductionmentioning
confidence: 99%